Zhende Ebitda vs Cost Of Revenue Analysis

603301 Stock

23.29 0.29 1.26%

Zhende Medical financial indicator trend analysis is more than just analyzing Zhende Medical current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Zhende Medical is a good investment. Please check the relationship between Zhende Medical Ebitda and its Cost Of Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Zhende Medical Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Ebitda vs Cost Of Revenue

Ebitda vs Cost Of Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Zhende Medical Ebitda account and Cost Of Revenue. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Zhende Medical's Ebitda and Cost Of Revenue is 0.91. Overlapping area represents the amount of variation of Ebitda that can explain the historical movement of Cost Of Revenue in the same time period over historical financial statements of Zhende Medical Co, assuming nothing else is changed. The correlation between historical values of Zhende Medical's Ebitda and Cost Of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebitda of Zhende Medical Co are associated (or correlated) with its Cost Of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost Of Revenue has no effect on the direction of Ebitda i.e., Zhende Medical's Ebitda and Cost Of Revenue go up and down completely randomly.

Correlation Coefficient

0.91

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Ebitda

Cost Of Revenue

Cost of Revenue is found on Zhende Medical income statement and represents the costs associated with goods and services Zhende Medical provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most indicators from Zhende Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Zhende Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Zhende Medical Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

As of November 29, 2024, Tax Provision is expected to decline to about 5.2 M. In addition to that, Selling General Administrative is expected to decline to about 394.3 M

	2021	2022	2023	2024 (projected)
Gross Profit	1.8B	2.1B	1.4B	1.6B
Total Revenue	5.1B	6.1B	4.1B	4.3B

Gross Profit Total Revenue

Zhende Medical fundamental ratios Correlations

	Other Liab	Net Tangible Assets	Retained Earnings	Other Assets	Common Stock	Property Plant Equipment	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Net Receivables	Good Will	Non Current Liabilities Total	Inventory	Other Current Assets	Total Liab	Short Long Term Debt	Total Current Assets	Short Term Debt	Intangible Assets	Net Debt
Other Liab		0.91	0.85	0.89	0.83	0.98	0.88	0.03	0.77	0.88	0.79	0.77	0.91	-0.71	0.54	0.83	0.95	0.77	0.79	0.46	0.83	-0.27	0.77	-0.82	0.9	-0.7
Net Tangible Assets	0.91		0.94	1.0	0.92	0.96	0.95	0.38	0.93	0.94	0.91	0.91	0.88	-0.82	0.54	0.93	0.85	0.74	0.95	0.66	0.93	-0.27	0.93	-0.84	0.84	-0.82
Retained Earnings	0.85	0.94		0.94	0.97	0.9	0.99	0.4	0.95	0.99	0.95	0.95	0.94	-0.74	0.56	0.96	0.75	0.78	0.97	0.63	0.97	-0.23	0.96	-0.67	0.92	-0.78
Other Assets	0.89	1.0	0.94		0.92	0.95	0.95	0.41	0.94	0.94	0.92	0.91	0.87	-0.79	0.54	0.93	0.83	0.73	0.96	0.67	0.94	-0.26	0.94	-0.83	0.83	-0.8
Common Stock	0.83	0.92	0.97	0.92		0.87	0.98	0.42	0.91	0.97	0.91	0.92	0.94	-0.81	0.63	0.95	0.73	0.82	0.96	0.63	0.95	-0.25	0.93	-0.71	0.91	-0.85
Property Plant Equipment	0.98	0.96	0.9	0.95	0.87		0.92	0.13	0.84	0.92	0.84	0.83	0.93	-0.76	0.57	0.88	0.95	0.79	0.86	0.53	0.89	-0.28	0.84	-0.86	0.91	-0.75
Total Assets	0.88	0.95	0.99	0.95	0.98	0.92		0.35	0.94	1.0	0.95	0.95	0.95	-0.78	0.63	0.97	0.79	0.84	0.97	0.58	0.97	-0.31	0.96	-0.73	0.93	-0.81
Other Current Liab	0.03	0.38	0.4	0.41	0.42	0.13	0.35		0.6	0.3	0.5	0.48	0.11	-0.29	0.02	0.44	-0.13	0.03	0.54	0.81	0.45	0.34	0.54	-0.05	0.03	-0.35
Total Current Liabilities	0.77	0.93	0.95	0.94	0.91	0.84	0.94	0.6		0.91	0.98	0.97	0.81	-0.73	0.51	0.97	0.63	0.69	0.98	0.79	0.97	-0.1	0.98	-0.62	0.77	-0.77
Total Stockholder Equity	0.88	0.94	0.99	0.94	0.97	0.92	1.0	0.3	0.91		0.93	0.94	0.97	-0.78	0.62	0.95	0.8	0.83	0.95	0.53	0.95	-0.36	0.94	-0.73	0.95	-0.81
Accounts Payable	0.79	0.91	0.95	0.92	0.91	0.84	0.95	0.5	0.98	0.93		1.0	0.83	-0.77	0.62	0.99	0.65	0.77	0.97	0.68	0.98	-0.23	0.99	-0.63	0.81	-0.8
Cash	0.77	0.91	0.95	0.91	0.92	0.83	0.95	0.48	0.97	0.94	1.0		0.83	-0.78	0.66	0.98	0.64	0.79	0.97	0.63	0.98	-0.32	0.99	-0.63	0.81	-0.81
Non Current Assets Total	0.91	0.88	0.94	0.87	0.94	0.93	0.95	0.11	0.81	0.97	0.83	0.83		-0.71	0.6	0.87	0.86	0.85	0.85	0.42	0.88	-0.33	0.83	-0.73	0.99	-0.73
Non Currrent Assets Other	-0.71	-0.82	-0.74	-0.79	-0.81	-0.76	-0.78	-0.29	-0.73	-0.78	-0.77	-0.78	-0.71		-0.67	-0.83	-0.66	-0.74	-0.81	-0.55	-0.79	0.29	-0.79	0.85	-0.72	0.99
Long Term Debt	0.54	0.54	0.56	0.54	0.63	0.57	0.63	0.02	0.51	0.62	0.62	0.66	0.6	-0.67		0.67	0.52	0.93	0.57	0.17	0.69	-0.53	0.61	-0.54	0.65	-0.66
Net Receivables	0.83	0.93	0.96	0.93	0.95	0.88	0.97	0.44	0.97	0.95	0.99	0.98	0.87	-0.83	0.67		0.7	0.82	0.97	0.68	0.99	-0.23	0.98	-0.69	0.86	-0.85
Good Will	0.95	0.85	0.75	0.83	0.73	0.95	0.79	-0.13	0.63	0.8	0.65	0.64	0.86	-0.66	0.52	0.7		0.74	0.68	0.3	0.72	-0.38	0.65	-0.89	0.86	-0.63
Non Current Liabilities Total	0.77	0.74	0.78	0.73	0.82	0.79	0.84	0.03	0.69	0.83	0.77	0.79	0.85	-0.74	0.93	0.82	0.74		0.74	0.29	0.84	-0.47	0.76	-0.67	0.89	-0.75
Inventory	0.79	0.95	0.97	0.96	0.96	0.86	0.97	0.54	0.98	0.95	0.97	0.97	0.85	-0.81	0.57	0.97	0.68	0.74		0.71	0.97	-0.25	0.99	-0.71	0.82	-0.84
Other Current Assets	0.46	0.66	0.63	0.67	0.63	0.53	0.58	0.81	0.79	0.53	0.68	0.63	0.42	-0.55	0.17	0.68	0.3	0.29	0.71		0.68	0.46	0.68	-0.39	0.36	-0.58
Total Liab	0.83	0.93	0.97	0.94	0.95	0.89	0.97	0.45	0.97	0.95	0.98	0.98	0.88	-0.79	0.69	0.99	0.72	0.84	0.97	0.68		-0.23	0.98	-0.68	0.87	-0.82
Short Long Term Debt	-0.27	-0.27	-0.23	-0.26	-0.25	-0.28	-0.31	0.34	-0.1	-0.36	-0.23	-0.32	-0.33	0.29	-0.53	-0.23	-0.38	-0.47	-0.25	0.46	-0.23		-0.27	0.39	-0.36	0.28
Total Current Assets	0.77	0.93	0.96	0.94	0.93	0.84	0.96	0.54	0.98	0.94	0.99	0.99	0.83	-0.79	0.61	0.98	0.65	0.76	0.99	0.68	0.98	-0.27		-0.66	0.8	-0.82
Short Term Debt	-0.82	-0.84	-0.67	-0.83	-0.71	-0.86	-0.73	-0.05	-0.62	-0.73	-0.63	-0.63	-0.73	0.85	-0.54	-0.69	-0.89	-0.67	-0.71	-0.39	-0.68	0.39	-0.66		-0.72	0.8
Intangible Assets	0.9	0.84	0.92	0.83	0.91	0.91	0.93	0.03	0.77	0.95	0.81	0.81	0.99	-0.72	0.65	0.86	0.86	0.89	0.82	0.36	0.87	-0.36	0.8	-0.72		-0.73
Net Debt	-0.7	-0.82	-0.78	-0.8	-0.85	-0.75	-0.81	-0.35	-0.77	-0.81	-0.8	-0.81	-0.73	0.99	-0.66	-0.85	-0.63	-0.75	-0.84	-0.58	-0.82	0.28	-0.82	0.8	-0.73

Click cells to compare fundamentals

Zhende Medical Account Relationship Matchups

Zhende Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Other Liab	45.6M	49.2M	98.9M	201.6M	231.8M	243.4M
Net Tangible Assets	959.4M	1.1B	3.8B	3.2B	3.7B	3.9B
Retained Earnings	446.3M	2.9B	3.0B	3.4B	3.1B	1.7B
Other Assets	22.6M	42.6M	153.2M	120.3M	138.4M	145.3M
Property Plant Equipment	630.0M	756.8M	1.5B	2.2B	2.5B	2.6B
Total Assets	2.7B	6.4B	6.4B	7.9B	7.3B	4.8B
Other Current Liab	89.4M	356.8M	176.3M	16.9M	1.4M	1.4M
Total Current Liabilities	798.3M	1.7B	1.6B	1.5B	1.2B	1.2B
Total Stockholder Equity	1.4B	4.2B	4.1B	5.5B	5.4B	3.1B
Accounts Payable	289.7M	636.3M	576.8M	702.7M	412.6M	436.2M
Cash	646.2M	1.8B	1.4B	2.1B	1.1B	1.0B
Non Current Assets Total	1.1B	2.0B	3.2B	3.8B	4.5B	2.3B
Non Currrent Assets Other	27.0M	112.8M	60.4M	62.8M	56.5M	53.7M
Long Term Debt	424.2M	95.1M	145.2M	388.4M	200.2M	179.1M
Net Receivables	389.7M	663.7M	690.4M	767.9M	539.6M	511.6M
Good Will	89.6M	130.4M	398.5M	474.5M	787.8M	827.2M
Non Current Liabilities Total	471.3M	194.0M	379.5M	621.2M	490.0M	323.5M
Inventory	430.9M	1.1B	833.5M	929.6M	800.8M	669.6M
Other Current Assets	87.2M	236.2M	265.6M	41.0M	64.1M	117.2M
Total Liab	1.3B	1.9B	2.0B	2.1B	1.7B	1.5B
Short Long Term Debt	292.5M	358.4M	660.7M	124.0M	220.1M	281.6M
Total Current Assets	1.6B	4.4B	3.2B	4.1B	2.7B	2.5B
Intangible Assets	185.1M	225.6M	444.8M	564.5M	607.1M	323.4M
Net Invested Capital	2.1B	4.6B	4.9B	6.1B	5.8B	4.1B
Net Working Capital	796.2M	2.6B	1.6B	2.6B	1.5B	1.5B

Currently Active Assets on Macroaxis

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C
MSFT	Microsoft
GM	General Motors

Other Information on Investing in Zhende Stock

Balance Sheet is a snapshot of the financial position of Zhende Medical at a specified time, usually calculated after every quarter, six months, or one year. Zhende Medical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Zhende Medical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Zhende currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Zhende Ebitda vs Cost Of Revenue Analysis

Ebitda vs Cost Of Revenue

Ebitda vs Cost Of Revenue Correlation Analysis

Correlation Coefficient

Ebitda

Cost Of Revenue

Zhende Medical fundamental ratios Correlations

Zhende Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Zhende Medical fundamental ratios Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in Zhende Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Other Assets	+ 1.0	Net Tangible Assets
Total Stockholder Equity	+ 1.0	Total Assets
Cash	+ 1.0	Accounts Payable
Total Assets	+ 0.99	Retained Earnings
Total Stockholder Equity	+ 0.99	Retained Earnings
Net Receivables	+ 0.99	Accounts Payable

Short Term Debt	- 0.89	Good Will
Short Term Debt	- 0.86	Property Plant Equipment
Net Debt	- 0.85	Net Receivables
Net Debt	- 0.85	Common Stock
Net Debt	- 0.84	Inventory
Short Term Debt	- 0.84	Net Tangible Assets